Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound [MSNBC.com]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: MSNBC.com
Eli Lillyobesity pilla late-stage trial The FDA in November said itawarded a priority reviewThe positive trial data suggest that the pill could be an effective treatment for patients to transition to if they want to preserve their weight loss but don't want to take weekly injections long-term. Many people who stop those shots regain much of the weight they initially shed.While Eli Lilly's pill appears to cause less weight loss overall than existing injections, Thursday's results highlight its potential role as a needle-free maintenance treatment in the blockbuster GLP-1 market. But an oral pill for obesity from Novo Nordisk will likely enter the market first, giving the Danish drugmaker a head start in staking its claim in the space.The phase three trial followed more than 300 patients with obesity who previously took Wegovy or Zepbound for 72 weeks in a separate late-stage study. Those people were then randomized to take either Eli Lilly's pill or a placebo for another 52 weeks. The
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Market Voices: Lilly's new obesity pill, NYSE owner eyes crypto firm [Seeking Alpha]Seeking Alpha
- Why Eli Lilly (LLY) Stock Is Trading Up Today [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and Company (NYSE:LLY) had its "neutral" rating reaffirmed by analysts at UBS Group AG.MarketBeat
- Medicare drug discounts begin in 2026. This is how much you'll save. [USA TODAY]USA TODAY
- Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound [CNBC]CNBC
LLY
Earnings
- 10/30/25 - Beat
LLY
Sec Filings
- 12/16/25 - Form 4
- 12/16/25 - Form 4
- 12/16/25 - Form 4
- LLY's page on the SEC website